Hayward Area Memorial Hospital | |
11040 N State Rd 77, Hayward, Wisconsin 54843 | |
(715) 934-4321 | |
Name | Hayward Area Memorial Hospital |
---|---|
Type | Critical Access Hospital |
Location | 11040 N State Rd 77, Hayward, Wisconsin |
Ownership | Voluntary non-profit - Private |
Emergency Services | Yes |
Medicare ID (CCN) | 521336 |
NPI Number | 1912992827 |
Organization Name | MEDICAL SERVICES, INC |
Doing Business As | TAMARACK HEALTH HAYWARD MEDICAL CENTER |
Address | 11040 N State Road 77, Hayward, WI 54843 |
Hospital Type | General Acute Care Hospital - Critical Access |
Phone Number | 715-934-4321 |
News Archive
Intrinsic Therapeutics today announced the enrollment of the 400th patient in a level 1, prospective, randomized, multi-center clinical trial evaluating the effectiveness of its Barricaid Prosthesis in improving outcomes for lumbar discectomy patients suffering from sciatica.
DNA breaks from radiation, toxic chemicals, or other environmental causes occur routinely in cells and, unless promptly and properly repaired, can lead to cancer-causing mutations.
A multi-institutional international study led by scientists at The University of Texas MD Anderson Cancer Center has revealed new information about how molecules called long non-coding RNAs (lncRNA) interact with HIF-1, a signaling pathway that is overexpressed in many cancers. HIF-1 has been shown to regulate breast cancer progression.
The National Institutes of Natural Sciences, National Institute for Fusion Science and The University of Tokyo Graduate School of Frontier Sciences Department of Advanced Materials Science research group have developed an electron density diagnostic method for atmospheric pressure low-temperature plasma that is anticipated to be applicable for the fields of environmental protection and of medicine and biology.
Repligen Corporation announced today that it has acquired the assets of BioFlash Partners, LLC, (BioFlash) including a technology platform for the production of pre-packed, "plug and play" chromatography columns. This patented technology enables economical production of chromatography columns in a format that is ready for use in the production of a broad range of biopharmaceuticals including monoclonal antibodies, vaccines and recombinant proteins.
› Verified 1 days ago
Able to receive lab results electronically | Yes |
Able to track patients' lab results, tests, and referrals electronically between visits | Yes |
News Archive
Intrinsic Therapeutics today announced the enrollment of the 400th patient in a level 1, prospective, randomized, multi-center clinical trial evaluating the effectiveness of its Barricaid Prosthesis in improving outcomes for lumbar discectomy patients suffering from sciatica.
DNA breaks from radiation, toxic chemicals, or other environmental causes occur routinely in cells and, unless promptly and properly repaired, can lead to cancer-causing mutations.
A multi-institutional international study led by scientists at The University of Texas MD Anderson Cancer Center has revealed new information about how molecules called long non-coding RNAs (lncRNA) interact with HIF-1, a signaling pathway that is overexpressed in many cancers. HIF-1 has been shown to regulate breast cancer progression.
The National Institutes of Natural Sciences, National Institute for Fusion Science and The University of Tokyo Graduate School of Frontier Sciences Department of Advanced Materials Science research group have developed an electron density diagnostic method for atmospheric pressure low-temperature plasma that is anticipated to be applicable for the fields of environmental protection and of medicine and biology.
Repligen Corporation announced today that it has acquired the assets of BioFlash Partners, LLC, (BioFlash) including a technology platform for the production of pre-packed, "plug and play" chromatography columns. This patented technology enables economical production of chromatography columns in a format that is ready for use in the production of a broad range of biopharmaceuticals including monoclonal antibodies, vaccines and recombinant proteins.
› Verified 1 days ago
Hayward Area Memorial Hospital Critical Access Hospital Location: 11040 N State Rd 77, Hayward, Wisconsin 54843 Phone: (715) 934-4321 |